carcinogen, microbiology
Deep-Sea Viruses Destroy Archaea
Deep-Sea Viruses Destroy Archaea
Ruth Williams | Oct 12, 2016
Viruses are responsible for the majority of archaea deaths on the deep ocean floors, scientists show.
Bacteria and Humans Have Been Swapping DNA for Millennia
Bacteria and Humans Have Been Swapping DNA for Millennia
Kelly Robinson and Julie Dunning Hotopp | Oct 1, 2016
Bacteria inhabit most tissues in the human body, and genes from some of these microbes have made their way to the human genome. Could this genetic transfer contribute to diseases such as cancer?
Life Scientists Receive “Genius” Grants
Life Scientists Receive “Genius” Grants
Ben Andrew Henry | Sep 22, 2016
Among this year’s 23 MacArthur Foundation Fellows are pioneering biologists.
Neonatal Gut Bacteria Might Promote Asthma
Neonatal Gut Bacteria Might Promote Asthma
Anna Azvolinsky | Sep 12, 2016
Byproducts of gut microbes in some 1-month–old babies trigger inflammation that is linked to later asthma development, researchers find.
Giant Petri Dish Displays Evolution in Space and Time
Giant Petri Dish Displays Evolution in Space and Time
Jenny Rood | Sep 8, 2016
As E. coli bacteria spread over increasingly concentrated antibiotics, researchers discover novel evolutionary pathways that confer resistance.
Promoting Protein Partnerships
Promoting Protein Partnerships
Ruth Williams | Sep 1, 2016
Scientists generate new protein-protein interactions at an impressive PACE.
Protein or Perish
Protein or Perish
Ruth Williams | Aug 31, 2016
A bacteriophage must evolve certain variants of a protein or die.
Stem Cells Drive Cancer Risk in Mice
Stem Cells Drive Cancer Risk in Mice
Jef Akst | Aug 26, 2016
Mutations that arise during stem cell division contribute to the development of cancers in a variety of organs, according to a study.
Antibiotic Resistance Reaches Brazil
Antibiotic Resistance Reaches Brazil
Kerry Grens | Aug 8, 2016
Scientists detect a colistin-resistance gene in a clinical sample.
Fecal Transplant Pill Fails Trial
Fecal Transplant Pill Fails Trial
Jef Akst | Aug 1, 2016
Seres Therapeutics’s microbiome-targeting therapy for recurrent Clostridium difficile infection fails a Phase 2 clinical trial.